Akari Therapeutics Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 2.72 M | $787.23 K | 100.00% | 833,957.74% |
| CRESSET ASSET MANAGEMENT, LLC | 02/17/2026 | 822.47 K | $237.69 K | 0.00% | 251,803.27% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2026 | 308.34 K | $88.71 K | 100.00% | 94,400.05% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 146.02 K | $42.20 K | 0.00% | 44,706.08% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 79.24 K | $22.90 K | 0.00% | 24,258.55% |
| JANE STREET GROUP, LLC | 02/12/2026 | 71.64 K | $20.71 K | 100.00% | 21,934.22% |
| 02/12/2026 | 69.25 K | $20.01 K | 100.00% | 21,200.67% | |
| CWA ASSET MANAGEMENT GROUP, LLC | 01/07/2026 | 55.00 K | $15.90 K | 100.00% | 16,838.56% |
| XTX TOPCO LTD | 02/17/2026 | 49.02 K | $14.17 K | 100.00% | 15,007.45% |
| UBS GROUP AG | 01/29/2026 | 32.86 K | $9.50 K | 54,658.33% | 10,058.75% |
| STONEX GROUP INC. | 02/12/2026 | 21.30 K | $6.15 K | 100.00% | 6,519.59% |
| CERITY PARTNERS LLC | 02/11/2026 | 23.64 K | $6.83 K | 0.00% | 7,238.44% |
| 02/18/2026 | 20.58 K | $5.95 M | 100.00% | 6,299.15% | |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 6.80 K | $1.97 K | 0.00% | 2,081.86% |
| ACCENT CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.00 K | $1.45 K | -50.00% | 1,530.78% |
| INDEPENDENT ADVISOR ALLIANCE | 02/04/2026 | 17.08 K | $4.94 K | 56.84% | 5,227.61% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 410 | $118 | 173.33% | 125.52% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 200 | $58 | 100.00% | 61.23% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 50 | $14 | 0.00% | 15.31% |
| CORNERSTONE PLANNING GROUP LLC | 02/02/2026 | 5 | $1 | -28.57% | 1.53% |
| MORGAN STANLEY | 02/13/2026 | 3 | $1 | 0.00% | 0.92% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 0 | $0 | -100.00% | 0.00% |
| OMNIA FAMILY WEALTH, LLC | 01/16/2026 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akari Therapeutics Plc institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Akari Therapeutics Plc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 2.72 M
Cresset Asset Management, LLC: 822,468
Warberg Asset Management LLC: 308,340
Palo Alto Investors LP: 146,024
HighTower Advisors, LLC: 79,236
JANE STREET GROUP, LLC: 71,644
1,363,267.28% of Akari Therapeutics Plc stock is owned by institutional investors.
Institutional investors have bought a total of 4.53 M shares in the last 24 months. This purchase volume represents approximately $1.09 M in transactions.